Study of Tysabri (Natalizumab) in Patients Who Failed Anti-TNF-α Therapy

Safety and Efficacy of Natalizumab in Combination With Remicade in the Treatment of Crohn's Disease

NCT00055536 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of the Safety, Tolerability, and Efficacy of MDGN-002 in Adults With Moderate to Severe Active Crohn's Disease or Ulcerative Colitis

NCT03169894 ·Status: TERMINATED ·Phase: PHASE1

CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring

NCT00707512 ·Status: TERMINATED

VTX958 for the Treatment of Moderately to Severely Active Crohn's Disease

NCT05688852 ·Status: TERMINATED ·Phase: PHASE2

Monoclonal Antibody Treatment of Crohn's Disease

NCT00007163 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate Safety, Tolerability and Efficacy of GSK2330811 in Crohn's Disease

NCT04151225 ·Status: WITHDRAWN ·Phase: PHASE2

A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1)

NCT01369329 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Efficacy and Safety of PF-06480605 in Adult Participants With Moderate to Severe Crohn's Disease

NCT05471492 ·Status: WITHDRAWN ·Phase: PHASE2

A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease

NCT00055523 ·Status: COMPLETED ·Phase: PHASE2

A Study of Abatacept in Patients With Active Crohn's Disease

NCT00406653 ·Status: TERMINATED ·Phase: PHASE3

A Study of Darvadstrocel in Adults With Crohn's Disease and Complex Perianal Fistula

NCT04118088 ·Status: TERMINATED ·Phase: PHASE4

Thalidomide Versus Infliximab in New Onset Crohn's Disease With Poor Prognostic Factors

NCT03221166 ·Status: TERMINATED ·Phase: PHASE3

Efficacy and Safety of Oral BT-11 in Moderate to Severe Crohn's Disease

NCT03870334 ·Status: TERMINATED ·Phase: PHASE2

Efficacy and Safety of Two Treatment Algorithms in Adults With Moderate to Severe Crohn's Disease

NCT01235689 ·Status: COMPLETED ·Phase: PHASE3

Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohn's Disease

NCT00138840 ·Status: COMPLETED ·Phase: PHASE2

The Immunological and Blood Effects of STA-5326 Mesylate on Patients With Crohn's Disease

NCT00250198 ·Status: COMPLETED ·Phase: PHASE2

A Study of Ustekinumab (STELARA) in Chinese Participants With Moderately to Severely Active Crohn's Disease

NCT05029921 ·Status: COMPLETED ·Phase: PHASE4

Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144

NCT02403323 ·Status: TERMINATED ·Phase: PHASE3

Treatment of Perianal Crohn's Disease, Combining Medical and Surgical Treatment.

NCT00252369 ·Status: TERMINATED ·Phase: NA

Efficacy and Safety of TD-1473 in Crohn's Disease

NCT03635112 ·Status: TERMINATED ·Phase: PHASE2

Long-term Safety Study of Brodalumab in Adults With Crohn's Disease

NCT01199302 ·Status: TERMINATED ·Phase: PHASE2

A Phase II Study to Assess the Efficacy and Safety of Olokizumab in Patients With Crohn's Disease

NCT01635621 ·Status: WITHDRAWN ·Phase: PHASE2

A Study of the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

NCT03105128 ·Status: COMPLETED ·Phase: PHASE3

An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Crohn's Disease

NCT00269854 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease

NCT01203631 ·Status: COMPLETED ·Phase: PHASE2